Fusion event
HBV-chr9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCAT| |AAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTG
End
47180646/41775105 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/541270; hsa-let-7a-1/Downstream/29034870;
Upstream sequence
AATGCAATTTATGATATGTCAAGTAGACCTCAATAGAGCTGTTTTAAAACATACAACAGAATTTCCCGCAACCCAACCACACCACCCGCGCCATCACACG
Downstream sequence
GACCCAGAGAGCCCATGGGCAGACAGTCTTGGTGCTGCATGCCCGGGCTTAAACCAGCAAGCCTGATTCTGAATGTCCACAAGCTCTTGGCTGGTGGGGC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.